FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Amerisource Health Services Meclizine Hydrochloride Tablets Recall

Meclizine Hydrochloride Tablets, USP 12

Amerisource Health Services LLC · Columbus, OH

Risk level
Class II
Reported by FDA
Apr 1, 2026
Recall ID
D-0418-2026
Check your lot numberHow we source this data

Summary

Amerisource Health Services recalled Meclizine Hydrochloride Tablets starting Mar 16, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0418-2026 on Apr 1, 2026. Reason: Failed tablet specifications. Status: Ongoing.

Why it was recalled

Failed tablet specifications.

Product description

Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.

Lot numbers, UPCs & expiration codes

Lot #1024852; Exp 9/30/2026

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0418-2026
Classification
Class II
Status
Ongoing
Recall initiated
Mar 16, 2026
FDA report date
Apr 1, 2026
Quantity
697 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Amerisource Health Services LLC

Original FDA data

Every field from FDA enforcement report D-0418-2026, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Ongoing
Country
United States
Event ID
98526
Address
2550 John Glenn Ave Ste A
Code information
Lot #1024852; Exp 9/30/2026
Postal code
43217-1188
Report date
Apr 1, 2026
Product type
Drugs
Recall number
D-0418-2026
Classification
Class II
Recalling firm
Amerisource Health Services LLC
Product quantity
697 cartons
Reason for recall
Failed tablet specifications.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
Distribution pattern
U.S. Nationwide
Recall initiation date
Mar 16, 2026
Initial firm notification
Letter
Center classification date
Mar 31, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0418-2026, published Apr 1, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls